| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.71▲ | 0.71▲ | 0.71▲ | 0.76▼ | 0.77▼ |
| MA10 | 0.71▲ | 0.71▲ | 0.70▲ | 0.79▼ | 0.78▼ |
| MA20 | 0.71▲ | 0.70▲ | 0.71▲ | 0.79▼ | 0.74▼ |
| MA50 | 0.69▲ | 0.73▼ | 0.76▼ | 0.78▼ | 0.82▼ |
| MA100 | 0.70▲ | 0.77▼ | 0.79▼ | 0.74▼ | 0.86▼ |
| MA200 | 0.75▼ | 0.78▼ | 0.79▼ | 0.77▼ | 2.24▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.005▲ | 0.004▲ | -0.012▼ | 0.008▲ |
| RSI | 57.237▲ | 51.648▲ | 44.983▼ | 36.166▼ | 45.073▼ |
| STOCH | 41.667 | 77.934 | 80.796▲ | 28.432 | 45.431 |
| WILL %R | -34.363 | -14.332▲ | -12.678▲ | -77.473▼ | -75.446▼ |
| CCI | 22.899 | 83.982 | 110.285▲ | -196.799▼ | -44.762 |
|
Thursday, November 13, 2025 04:43 AM
Reported late-breaking Phase 2 data at SITC for vilastobart demonstrating a 40% ORR in heavily pretreated patients with MSS mCRC without liver metastases and high plasma tumor mutational burden Presen ...
|
|
Thursday, November 13, 2025 04:42 AM
Based on its current operating plans, Xilio anticipates that its cash and cash equivalents as of September 30, 2025, together with the $17.5 ...
|
|
Friday, November 07, 2025 06:21 AM
Xilio Therapeutics (XLO) announced new data across its portfolio, including preclinical data highlighting the potential for Xilio’s masked T cell ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 0.66 | 0.724 | 0.66 | 0.707 | 446,400 |
| 13/11/25 | 0.745 | 0.7463 | 0.6512 | 0.7015 | 1,530,015 |
| 12/11/25 | 0.772 | 0.794 | 0.747 | 0.773 | 379,300 |
| 11/11/25 | 0.795 | 0.80 | 0.738 | 0.794 | 854,600 |
| 10/11/25 | 0.83 | 0.839 | 0.756 | 0.805 | 1,234,800 |
| 07/11/25 | 0.85 | 0.85 | 0.773 | 0.807 | 1,903,500 |
| 06/11/25 | 0.8022 | 0.848 | 0.7842 | 0.8316 | 1,236,205 |
| 05/11/25 | 0.80 | 0.8336 | 0.80 | 0.8154 | 1,076,095 |
| 04/11/25 | 0.85 | 0.8583 | 0.7927 | 0.8018 | 1,027,707 |
| 03/11/25 | 0.80 | 0.88 | 0.80 | 0.85 | 1,536,900 |
|
|
||||
|
|
||||
|
|